Serum level of macrophage colony-stimulating factor is increased in prostate cancer patients with bone metastasis

Human Cell

Volumn 21, Issue 1, 2008, Pages 1-6

  Ide, Hisamitsu ^a   Hatake, Kiyohiko ^b   Terado, Yuichi ^c   Tsukino, Hiroyuki ^d   Okegawa, Takatsugu ^c   Nutahara, Kikuo ^c   Higashihara, Eiji ^c   Horie, Shigeo ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CANCER CHEMOTHERAPY CENTER   (Japan)

^c KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Bone metastasis; Macrophage colony stimulating factor; Prostate cancer

Indexed keywords

COLONY STIMULATING FACTOR 1;

AGED; ANALYTIC METHOD; ARTICLE; BONE METASTASIS; CANCER GROWTH; CONTROLLED STUDY; GLEASON SCORE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR GROWTH;

ADENOCARCINOMA; AGED; BONE NEOPLASMS; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 38049069222     PISSN: 09147470     EISSN: 17490774     Source Type: Journal    
DOI: 10.1111/j.1749-0774.2007.00042.x     Document Type: Article

References (26)

1. Djakiew D. Dysregulated expression of growth factors and their receptors in the development of prostate cancer. Prostate 2000 42 : 150 60.
2. Ware JL. Growth factor network disruption in prostate cancer progression. Cancer Metastasis Rev 1998 17 : 443 7.
3. Ide H, Seligson DB, Memarzadeh S et al. Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression. Proc Natl Acad Sci USA 2002 99 : 14404 9.
4. Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 1985 41 : 665 76.
5. Roussel MF, Sherr CJ. Mouse NIH 3T3 cells expressing human colony-stimulating factor 1 (CSF-1) receptors overgrow in serum-free medium containing human CSF-1 as their only growth factor. Proc Natl Acad Sci USA 1989 86 : 7924 7.
6. Roth P, Stanley ER. The biology of CSF-1 and its receptor. Curr Top Microbiol Immunol 1992 181 : 141 67.
7. Pollard JW. Role of colony-stimulating factor-1 in reproduction and development. Mol Reprod Dev 1997 46 : 54 60 discussion 60-1.
8. Sapi E, Kacinski BM. The role of CSF-1 in normal and neoplastic breast physiology. Proc Soc Exp Biol Med 1999 220 : 1 8.
9. Rijnders AW, van der Korput JA, van Steenbrugge GJ, Romijn JC, Trapman J. Expression of cellular oncogenes in human prostatic carcinoma cell lines. Biochem Biophys Res Commun 1985 132 : 548 54.
10. Savarese DM, Valinski H, Quesenberry P, Savarese T. Expression and function of colony-stimulating factors and their receptors in human prostate carcinoma cell lines. Prostate 1998 34 : 80 91.
11. Seelentag WK, Mermod JJ, Montesano R, Vassalli P. Additive effects of interleukin 1 and tumour necrosis factor-alpha on the accumulation of the three granulocyte and macrophage colony-stimulating factor mRNAs in human endothelial cells. EMBO J 1987 6 : 2261 5.
12. Yoshida H, Hayashi S, Kunisada T et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990 345 : 442 4.
13. Ryan GR, Dai XM, Dominguez MG et al. Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1 (op)/Csf1 (op) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis. Blood 2001 98 : 74 84.
14. Kacinski BM. CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract. Mol Reprod Dev 1997 46 : 71 4.
15. Hakala A, Kacinski BM, Stanley ER et al. Macrophage colony-stimulating factor 1, a clinically useful tumor marker in endometrial adenocarcinoma: comparison with CA 125 and the aminoterminal propeptide of type III procollagen. Am J Obstet Gynecol 1995 173 : 112 19.
16. Kuropkat C, Duenne AA, Herz U, Renz H, Werner JA. Significant correlation of matrix metalloproteinase and macrophage colony-stimulating factor serum concentrations in patients with head and neck cancer. Neoplasma 2004 51 : 375 8.
17. Mroczko B, Szmitkowski M, Okulczyk B. Granulocyte-colony stimulating factor (G-CSF) and macrophagecolony stimulating factor (M-CSF) in colorectal cancer patients. Clin Chem Lab Med 2002 40 : 351 5.
18. McDermott RS, Deneux L, Mosseri V et al. Circulating macrophage colony stimulating factor as a marker of tumour progression. Eur Cytokine Netw 2002 13 : 121 7.
19. Igarashi H, Hatake K, Tomizuka H, Yamada M, Gunji Y, Momoi MY. High serum levels of M-CSF and G-CSF in Kawasaki disease. Br J Haematol 1999 105 : 613 15.
20. Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001 193 : 727 40.
21. Keshava N, Gubba S, Tekmal RR. Overexpression of macrophage colony-stimulating factor (CSF-1) and its receptor, c-fms, in normal ovarian granulosa cells leads to cell proliferation and tumorigenesis. J Soc Gynecol Investig 1999 6 : 41 9.
22. Pei XH, Nakanishi Y, Takayama K, Bai F, Hara N. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells. Br J Cancer 1999 79 : 40 6.
23. Scher HI, Yagoda A. Bone metastases: pathogenesis, treatment, and rationale for use of resorption inhibitors. Am J Med 1987 82 : 6 28.
24. Cecchini MG, Hofstetter W, Halasy J, Wetterwald A, Felix R. Role of CSF-1 in bone and bone marrow development. Mol Reprod Dev 1997 46 : 75 83 discussion 83-4.
25. Aharinejad S, Paulus P, Sioud M et al. Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice. Cancer Res 2004 64 : 5378 84.
26. Dorai T, Dutcher JP, Dempster DW, Wiernik PH. Therapeutic potential of curcumin in prostate cancer-V: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells. Prostate 2004 60 : 1 17.